Amentum vs Verisk Analytics: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Amentum Holdings Inc. (AMTM)

Q3 202630 Jun – 19 Aug 2026

▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.
New contract award directly boosts AMTM's demand outlook.
Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.
This is the main earnings event that moved the stock sharply both ways.
UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.
New contract expands AMTM's addressable market and revenue visibility.
NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.
It is a new, specific negative factor that tempers the positive outlook.

July 202630 Jun – 19 Aug 2026

▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.
New contract award directly boosts AMTM's demand outlook.
Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.
This is the main earnings event that moved the stock sharply both ways.
UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.
New contract expands AMTM's addressable market and revenue visibility.
NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.
It is a new, specific negative factor that tempers the positive outlook.

Latest30 Jun – 19 Aug 2026

▲2▼1

Amentum's profit beat and new contract wins offset revenue miss and NASA headwind

NASA COSMOS contract win Amentum won NASA's COSMOS contract to run mission operations and astronaut training for Artemis, the Space Station and more. This adds long-term work and supports future revenue, helping lift the stock.
New contract award directly boosts AMTM's demand outlook.
Q2 revenue miss but raised profit guidance Q2 revenue fell short and the stock dropped 15%, but the company raised its full-year profit and earnings guidance, with net income jumping. The market first focused on the miss, then on the improved profitability.
This is the main earnings event that moved the stock sharply both ways.
UK defence framework with Babcock Amentum joined a five-year Babcock framework to support UK defence programmes, including nuclear and submarine work. This secures steady, long-term engineering revenue and strengthens its international defence business.
New contract expands AMTM's addressable market and revenue visibility.
NASA workforce directive cuts 2027 revenue Amentum said NASA's workforce directive will cut about 3% from fiscal 2027 revenue, though the rest of the business should grow mid-single digits. This is a real headwind that partly offsets the new contract wins.
It is a new, specific negative factor that tempers the positive outlook.

Verisk Analytics Inc (VRSK)

Q3 20262 Jul – 10 Aug 2026

▲2▼2

Verisk's growth steady, but court revives $2.35B AccuLynx deal

Q2 revenue up 4.3%, buyback announced Verisk reported second-quarter revenue of $806 million, up 4.3% from a year ago, with adjusted profit rising and adjusted earnings per share up 5.3% to $1.98. The company also announced a $200 million accelerated share buyback and reaffirmed its full-year outlook. Steady growth and cash returned to shareholders support the stock.
This is the core earnings update that shows the business is growing and returning cash, a fundamental positive for the stock.
Catastrophe loss estimates keep Verisk in demand Verisk issued loss estimates for the Venezuela earthquakes (over $10 billion economic) and the Kumamoto, Japan earthquake (insured losses $1.4–2.1 billion). These events highlight demand for Verisk's risk modeling services, as insurers and others rely on its estimates after disasters. More frequent catastrophes can drive long-term demand for its products.
Shows a recurring demand driver for Verisk's core catastrophe modeling business, which can support future revenue.
Court forces Verisk to pursue AccuLynx deal A Delaware judge ruled that Verisk must try to complete its $2.35 billion acquisition of AccuLynx, which Verisk had terminated in December. The judge found Verisk's withdrawal invalid and said AccuLynx can recover costs. The deal still needs FTC approval, so uncertainty and potential financial burden weigh on the stock.
This legal setback creates uncertainty and potential costs, directly pressuring the stock price.
Market reacts sharply to court ruling Verisk shares fell more than 6.5% after the Delaware court decision, reflecting investor concern about the forced acquisition and its unresolved regulatory review. The drop shows the market sees the ruling as a negative, at least in the short term, due to added uncertainty and potential integration costs.
Captures the immediate market impact of the court ruling, confirming it as a negative driver.

July 20262 Jul – 10 Aug 2026

▲2▼2

Verisk's growth steady, but court revives $2.35B AccuLynx deal

Q2 revenue up 4.3%, buyback announced Verisk reported second-quarter revenue of $806 million, up 4.3% from a year ago, with adjusted profit rising and adjusted earnings per share up 5.3% to $1.98. The company also announced a $200 million accelerated share buyback and reaffirmed its full-year outlook. Steady growth and cash returned to shareholders support the stock.
This is the core earnings update that shows the business is growing and returning cash, a fundamental positive for the stock.
Catastrophe loss estimates keep Verisk in demand Verisk issued loss estimates for the Venezuela earthquakes (over $10 billion economic) and the Kumamoto, Japan earthquake (insured losses $1.4–2.1 billion). These events highlight demand for Verisk's risk modeling services, as insurers and others rely on its estimates after disasters. More frequent catastrophes can drive long-term demand for its products.
Shows a recurring demand driver for Verisk's core catastrophe modeling business, which can support future revenue.
Court forces Verisk to pursue AccuLynx deal A Delaware judge ruled that Verisk must try to complete its $2.35 billion acquisition of AccuLynx, which Verisk had terminated in December. The judge found Verisk's withdrawal invalid and said AccuLynx can recover costs. The deal still needs FTC approval, so uncertainty and potential financial burden weigh on the stock.
This legal setback creates uncertainty and potential costs, directly pressuring the stock price.
Market reacts sharply to court ruling Verisk shares fell more than 6.5% after the Delaware court decision, reflecting investor concern about the forced acquisition and its unresolved regulatory review. The drop shows the market sees the ruling as a negative, at least in the short term, due to added uncertainty and potential integration costs.
Captures the immediate market impact of the court ruling, confirming it as a negative driver.

Latest2 Jul – 10 Aug 2026

▲2▼2

Verisk's growth steady, but court revives $2.35B AccuLynx deal

Q2 revenue up 4.3%, buyback announced Verisk reported second-quarter revenue of $806 million, up 4.3% from a year ago, with adjusted profit rising and adjusted earnings per share up 5.3% to $1.98. The company also announced a $200 million accelerated share buyback and reaffirmed its full-year outlook. Steady growth and cash returned to shareholders support the stock.
This is the core earnings update that shows the business is growing and returning cash, a fundamental positive for the stock.
Catastrophe loss estimates keep Verisk in demand Verisk issued loss estimates for the Venezuela earthquakes (over $10 billion economic) and the Kumamoto, Japan earthquake (insured losses $1.4–2.1 billion). These events highlight demand for Verisk's risk modeling services, as insurers and others rely on its estimates after disasters. More frequent catastrophes can drive long-term demand for its products.
Shows a recurring demand driver for Verisk's core catastrophe modeling business, which can support future revenue.
Court forces Verisk to pursue AccuLynx deal A Delaware judge ruled that Verisk must try to complete its $2.35 billion acquisition of AccuLynx, which Verisk had terminated in December. The judge found Verisk's withdrawal invalid and said AccuLynx can recover costs. The deal still needs FTC approval, so uncertainty and potential financial burden weigh on the stock.
This legal setback creates uncertainty and potential costs, directly pressuring the stock price.
Market reacts sharply to court ruling Verisk shares fell more than 6.5% after the Delaware court decision, reflecting investor concern about the forced acquisition and its unresolved regulatory review. The drop shows the market sees the ruling as a negative, at least in the short term, due to added uncertainty and potential integration costs.
Captures the immediate market impact of the court ruling, confirming it as a negative driver.